Passive Income for Life: My 7 Favorite Evergreen Dividend Stocks

Want freedom from your 9-to-5? Who doesn't! One of the best ways is to build up a portfolio of dividend stocks kicking off passive cash flow each month. I've assembled a squad of 7 all-star dividend payers that deliver over $500 per month in recurring income.

These stocks may not be the flashiest picks - you won't find crypto or meme stocks here! But they provide the priceless gift of stability and peace of mind that we all crave, especially during volatile markets.

So let's meet the passive income all-stars!

Kicking Off With Good Ol' Reliable JPMorgan Chase

Kicking things off is good ol' reliable JPMorgan Chase, the financial services giant. We're talking a massive balance sheet flush with over $700 billion in cash. That's Grade A security right there.

And with interest rates on the rise, JPMorgan is lining its pockets by arbitraging rates. The Federal Reserve is battling inflation head-on with rate hikes, and banks like JPMorgan come out winners. So as rates keep rising, so will JPMorgan's net interest income. Cha-ching!

JPMorgan really instills confidence too since they survived 2008 unscathed while fellow banks crumbled. When the next crisis hits, JPMorgan's fortress of a balance sheet should withstand the turbulence.

For all these reasons, JPMorgan Chase provides nice recurring income while allowing me to sleep well at night. The dividend yield fluctuates around 3-4%, translating to about $4 annually per share.

Next Up - Pharma Juggernaut AbbVie

Next up is pharma juggernaut AbbVie, maker of the blockbuster drug Humira. This arthritis treatment is no joke - Humira delivered $19 billion in sales in 2019 alone!

While I don't love everything about Big Pharma, you can't deny AbbVie's money-making machine. Humira revenue has exceeded $20 billion annually in recent years. That's just one drug!

Plus, AbbVie is cooking up new drug formulas in their labs as we speak. They plow billions into R&D each year to expand their pipeline. This ensures they aren't over-reliant on Humira, despite its dominance.

Now Humira does lose patent exclusivity in 2023, opening it to competition. But AbbVie's deep pockets and pipeline investments could offset this challenge.

At a yield fluctuating around 4-5%, AbbVie provides nice diversification and recurring income. That translates to $5-6 annually per share.

Not bad for a single investment!

PepsiCo - Iconic Brands + Pricing Power

Speaking of iconic brands, PepsiCo definitely delivers with their infectious jingles and their salty crunchy Frito-Lay snacks. Plus, they possess serious pricing power in this inflationary environment.

PepsiCo can pass along price increases to customers who just keep coming back. Their world-famous beverage and snack lineup is basically recession-proof. And you know Pepsi will outlive us all with their mouthwatering treats.

Between hit soda brands and Frito-Lay's market dominance, PepsiCo covers all the bases. This diversified product mix provides an edge over competitors like Coca-Cola.

PepsiCo's dividend yield tends to hover in the 2.5-3% range, meaning around $4-5 annually per share. The recurring passive income from this snacking powerhouse adds a nice sweetness to any dividend portfolio.

Kraft Heinz and Their Timeless Comfort Foods

Up next is Kraft Heinz and their comfort foods like mac and cheese that never go out of style. Warren Buffett himself is still a fan, with over 325 million shares in Berkshire Hathaway's portfolio.

Though fair warning, their growth is a bit ketchup-like. Revenues and profits have stalled a bit in recent years as consumers shift toward healthier fare.

But I'm not ready to write off this household name just yet. At a yield around 4.5%, Kraft Heinz provides ample income while we monitor their ability to adapt to changing tastes. That's around $1.60 annually per share.

As long as they keep pumping out classics like Oscar Mayer hot dogs, Velveeta cheesy goodness, and their namesake Kraft mac and cheese, the company should be fine. But I've got my eye on you, Kraft Heinz!

Yes, ExxonMobil Is Controversial But Hear Me Out

I'll admit ExxonMobil is a controversial pick with oil's sketchy future. But the reality is our world still runs on fossil fuels. And with oil prices spiking while geopolitical tensions flare up, Exxon is raking in the dough.

Exxon's profits are up a whopping 50% this year while the broader market sinks! And even compared to Big Tech names like Google down 30% this year, Exxon is flexing its muscles.

The dividend yield tends to hover in the 4% range, translating to around $3.50 annually for each share. That's a nice cash infusion from a single stock.

Yes, renewables are the inevitable future. But with infrastructure still overwhelmingly built for petroleum, Exxon continues pumping out dividends. I'll gladly collect them in the meantime!

Home Depot - My Home Away From Home

Then there's Home Depot, my home away from home for weekend projects! Whether it's homeowners tackling renovations or contractors building new properties, this big orange machine churns out cash with its effective duopoly.

See, the home improvement market is neatly split between Home Depot and rival Lowe's. This grants tremendous stability since where else will folks buy supplies en masse?

With the hot housing market, demand for home renovations is through the roof. But new construction hasn't kept pace, creating massive tailwinds for Home Depot.

Between homeowners and contractors, their customer base is diverse and revenues massive. We're talking $150 billion in sales annually!

At yields fluctuating around 2-3%, Home Depot provides recurring income of $7-8 per share annually. For investors seeking stability, Home Depot delivers.

Johnson & Johnson - The Definition of a Dividend Aristocrat

And finally, we have Johnson & Johnson. Band-Aids, Listerine, Tylenol - their brands are baked into our lives. And with 50+ consecutive years of dividend increases, you know Johnson & Johnson is serious about keeping shareholders happy.

Johnson & Johnson is the picture of resilience, providing calming dividends even when markets get rocky. The stock is actually up 1% this year while the overall market sinks - just showcasing its consistency.

They have a massive cash stockpile for security, over $20 billion last I checked. Plus an excellent AAA credit rating to boot.

With a yield typically between 2.5-3%, Johnson & Johnson sends around $4 annually per share into your brokerage account. Reliable brands, reliable dividends.

Final Thoughts

There you have it - my 7 pillars of passive income and early retirement. They may not be flashy picks, but slow and steady wins the race. With an average annual dividend of $500+ per month, these stocks provide recurring cash flow you can count on.

What dividend stocks do you love? Let me know! And don't forget to grab some free stocks from WeBull using my link below. Let's get that passive income rolling in!

Leave a Comment Cancel Reply

Exit mobile version